New FDA Guidance: What Review Boards Should Do
In the Federal Register is a draft guidance that provides institutional review boards (IRBs) with further instruction regarding their responsibilities to evaluate the qualifications of clinical investigators and the adequacy of...To view the full article, register now.
Already a subscriber? Click here to view full article